Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation that is in Phase Ia/Ib clinical trial in patients with solid tumors. The company''s pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma and solid tumors; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. The company was incorporated in 2000 and is headquartered in Lexington, Massachusetts.

CRIS price history

interval date selector

agregation type selector

Date

Change

Chg%

Open

Min.

Max.

2022-09-30

1.6178

-0.0299

-1.81

1.6477

1.6178

1.6477

2022-09-30

1.6377

-0.0200

-1.21

1.6577

1.6277

1.6577

2022-09-30

1.6677

0.0799

5.03

1.5878

1.6677

2022-09-30

1.6078

-0.0200

-1.23

1.6278

1.6078

1.6378

2022-09-30

1.6477

0.0200

1.23

1.6277

1.6078

1.6677

2022-09-30

1.6377

-0.0500

-2.96

1.6877

1.6278

1.7176

2022-09-30

1.6777

0.0599

3.70

1.6178

1.7676

2022-09-30

1.5279

-0.0299

-1.92

1.5578

1.458

1.5578

2022-09-30

1.5279

-0.0299

-1.92

1.5578

1.4879

1.5579

2022-09-30

1.5778

-0.0899

-5.39

1.6677

1.5678

1.6777

2022-09-30

1.6977

-0.0898

-5.02

1.7875

1.6677

1.7875

2022-09-30

1.7975

0.1498

9.09

1.6477

1.8375

2022-09-30

1.6377

-0.0200

-1.21

1.6577

1.6277

1.6877

2022-09-30

1.6577

-0.0100

-0.60

1.6677

1.6477

1.7376

Trade Curis, Inc. - CRIS stock price

The Power Of Leverage

CRIS price history